Group Interventions for Patients with Cancer and HIV Disease: Part I: Effects on Psychosocial and Functional Outcomes at Different Phases of Illness

2004 ◽  
Vol 54 (1) ◽  
pp. 29-82 ◽  
Author(s):  
Allen C. Sherman ◽  
Julie Mosier ◽  
Molyn Leszcz ◽  
Gary M. Burlingame ◽  
Kathleen H. Ulman ◽  
...  
Keyword(s):  
Functional Outcomes ◽  
Hiv Disease ◽  
Group Interventions ◽  
Patients With Cancer

Group Interventions for Patients With Cancer and HIV Disease: Part I: Efficacy at Different Phases of Illness

2013 ◽  
Author(s):  
Allen C. Sherman ◽  
Gary M. Burlingame ◽  
Trish Cleary ◽  
Bernhard Strauss ◽  
Umaira Latif ◽  
...  
Keyword(s):  
Hiv Disease ◽  
Group Interventions ◽  
Patients With Cancer

Group Interventions for Patients with Cancer and HIV Disease: Part III. Moderating Variables and Mechanisms of Action

2004 ◽  
Vol 54 (3) ◽  
pp. 347-387 ◽  
Author(s):  
Allen C. Sherman ◽  
Julie Mosier ◽  
Molyn Leszcz ◽  
Gary M. Burlingame ◽  
Kathleen Hubbs Ulman ◽  
...  
Keyword(s):  
Mechanisms Of Action ◽  
Hiv Disease ◽  
Group Interventions ◽  
Moderating Variables ◽  
Patients With Cancer

Group Interventions for Patients with Cancer and HIV Disease: Part IV. Clinical and Policy Recommendations

2004 ◽  
Vol 54 (4) ◽  
pp. 539-556 ◽  
Author(s):  
Molyn Leszcz ◽  
Allen Sherman ◽  
Julie Mosier ◽  
Gary M. Burlingame ◽  
Trish Cleary ◽  
...  
Keyword(s):  
Policy Recommendations ◽  
Hiv Disease ◽  
Group Interventions ◽  
Patients With Cancer

Group Interventions for Patients with Cancer and HIV Disease: Part II. Effects on Immune, Endocrine, and Disease Outcomes at Different Phases of Illness

2004 ◽  
Vol 54 (2) ◽  
pp. 203-233 ◽  
Author(s):  
Allen C. Sherman ◽  
Molyn Leszcz ◽  
Julie Mosier ◽  
Gary M. Burlingame ◽  
Trish Cleary ◽  
...  
Keyword(s):  
Hiv Disease ◽  
Group Interventions ◽  
Patients With Cancer ◽  
Disease Outcomes

Neurologic Complications in Patients with Cancer

2021 ◽  
Vol 41 (05) ◽  
pp. 588-605
Author(s):  
Kathryn B. Holroyd ◽  
Daniel B. Rubin ◽  
Henrikas Vaitkevicius
Keyword(s):  
Functional Outcomes ◽  
Malignant Lesion ◽  
Neurologic Complications ◽  
Systemic Complications ◽  
Neurologic Symptoms ◽  
Patients With Cancer ◽  
Mechanistic Approach ◽  
Underlying Pathophysiology

AbstractNeurologic symptoms are commonly seen in patients with cancer and can be among the most challenging to diagnose and manage. It is often difficult to determine if new neurologic symptoms are secondary to direct effects of a malignant lesion, systemic complications of disease, paraneoplastic disorders, or side effects of cancer treatment itself. However, early diagnosis and treatment of each of these conditions can improve patients' quality of life and long-term functional outcomes. In this review, we describe a systematic approach to the diagnosis of new neurologic symptoms in patients with known malignancy. We have categorized the neurologic complications of cancer through a mechanistic approach, with an emphasis on ascertaining underlying pathophysiology to guide treatment choice. This review focuses on the acute neurologic complications of cancer that require hospital admission.

Sign in / Sign up

Export Citation Format

Share Document